Literature DB >> 8192760

Debate on using adjuvant chemotherapy.

M Levine.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8192760      PMCID： PMC2380028     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  6 in total

1.  Treatment decisions in axillary node-negative breast cancer patients.

Authors:  W L McGuire; A K Tandon; D C Allred; G C Chamness; P M Ravdin; G M Clark
Journal:  J Natl Cancer Inst Monogr       Date:  1992

2.  A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer.

Authors:  M N Levine; A Gafni; B Markham; D MacFarlane
Journal:  Ann Intern Med       Date:  1992-07-01       Impact factor: 25.391

3.  Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases.

Authors:  C L Carter; C Allen; D E Henson
Journal:  Cancer       Date:  1989-01-01       Impact factor: 6.860

4.  An assessment of clinically useful measures of the consequences of treatment.

Authors:  A Laupacis; D L Sackett; R S Roberts
Journal:  N Engl J Med       Date:  1988-06-30       Impact factor: 91.245

Review 5.  Adjuvant chemotherapy in stage I breast cancer. More harm than benefit.

Authors:  C B Mueller
Journal:  Can Fam Physician       Date:  1993-10       Impact factor: 3.275

6.  Adjuvant CMF for node-negative and estrogen receptor-negative breast cancer patients.

Authors:  M Zambetti; G Bonadonna; P Valagussa; M G Daidone; D Coradini; P Bignami; G Contesso; R Silvestrini
Journal:  J Natl Cancer Inst Monogr       Date:  1992
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.